Logo
x

Search category

Subscribe Now

Santhera

Santhera Entered into an Exclusive License and Collaboration Agreement with Catalyst Pharmaceuticals for Vamorolone

Santhera Entered into an Exclusive License and Collaboration Agreement with Catalyst Pharmaceuticals for Vamorolone

  • June 20, 2023
Santhera Reports the MAA Submission to the MHRA for Vamorolone to Treat Duchenne Muscular Dystrophy

Santhera Reports the MAA Submission to the MHRA for Vamorolone to Treat Duchenne Muscular Dystrophy

  • March 3, 2023
Santhera Collaborates with Sperogenix to Develop and Commercialize Vamorolone for Rare Diseases in the Greater China

Santhera Collaborates with Sperogenix to Develop and Commercialize Vamorolone for Rare Diseases in the Greater China

  • January 4, 2022
PharmaShots Weekly Snapshots (May 31 - June 4, 2021)

PharmaShots Weekly Snapshots (May 31 - June 4, 2021)

  • June 4, 2021
Top 20 Biopharma Deal Terminations of 2020 Based on Total Deal Value

Top 20 Biopharma Deal Terminations of 2020 Based on Total Deal Value

  • February 11, 2021
PharmaShots Weekly Snapshot (Oct 5-9, 2020)

PharmaShots Weekly Snapshot (Oct 5-9, 2020)

  • October 9, 2020
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2023 PharmaShots - All Rights Reserved.